is a Japanese light novel series written by Kennoji. It was serialized online between 2016 and 2020 on the user-generated novel publishing website Shà Âsetsuka ni Narà Â. It was acquired by Linda Publishers, who have originally published two volumes with illustrations by Shà Âji Nigà  between February and June 2017 under their Red Rising Books imprint, before going bankrupt. Hifumi Shobà  later reacquired the series, who have published eight volumes with illustrations by Matsuuni from April 2018 to January 2023 under their Brave Novel imprint. A manga adaptation with art by Eri Haruno has been serialized online via Takeshobo's Web Comic Gamma Plus website since December 2018. Both the light novel and manga are licensed in North America by Seven Seas Entertainment. An anime television series adaptation produced by EMT Squared aired from July to September 2021.
Reiji Kirio, a former corporate wage slave, is suddenly transported to a fantasy world. Upon arrival, he discovers he possesses two skills, Appraise and Drug Discovery. They initially seem modest, but eventually prove extraordinarily useful, granting him unparalleled knowledge of medicine. Choosing to avoid combat and ambition, Reiji decides to pursue a peaceful livelihood by opening a small drugstore in a village, aiming to live a stress-free life, unlike the one he left behind.
He runs the shop with the help of Noela, a loyal canine girl, and Mina, a gentle ghost, treating a wide range of customers using his medicines and potions. His remedies address all kinds of ailments, drawing in elves, dragons, and other residents with unique needs. While Reiji's intention is a calm routine, his cheat-level abilities and growing reputation often lead to unexpectedly busy days.
The series was written by Kennoji and serialized online between 2016 and 2020 on the user-generated novel publishing website Shà Âsetsuka ni Narà Â. It was later acquired by Linda Publishers, who have originally published two volumes with illustrations by Shà Âji Nigà  between February and June 2017 under their Red Rising Books imprint, before going bankrupt. Hifumi Shobà  later reacquired the series, who published eight volumes with illustrations by Matsuuni from April 2018 to January 2023 under their Brave Novel imprint. The Brave Novel edition of light novel series is licensed in North America by Seven Seas Entertainment.
A manga adaptation with art by Eri Haruno has been serialized online via Takeshobo's Web Comic Gamma Plus website since December 2018 and has been collected in fourteen tankà Âbon volumes. The manga series is also licensed in North America by Seven Seas Entertainment.
An anime adaptation was announced by Hifumi Shobà  at Comiket 97 on December 28, 2019, later revealed to be a television series on May 25, 2020. The series is animated by EMT Squared and directed by Masafumi Satà Â, with Hiroko Kanasugi overseeing the series' scripts, Etsuko Sumimoto designing the characters, and Tomoki Kikuya composing the series' music. It aired from July 7 to September 22, 2021, on Tokyo MX, BS11, and AT-X. Akane Kumada performed the series' opening theme song "Kokoro Hayaru", while Jun Fukushima, Risae Matsuda, and Kumada performed the series' ending theme song "Mainichi Kashimashi Pharmacy". Crunchyroll streamed the series worldwide outside of Asia. Muse Communication licensed the series in South and Southeast Asia.
It was the first time for Risae and Satsumi Matsuda, who are twin sisters, to play main roles which are not related by blood.
Anime News Network's review of the first novel gave it a score of 3/5 stars, stating: "There is a lovely straightforward quality to the writing and the story that lets us know that KennojiÃÂ isn't winking and nudging towards any deeper plan, but it really is, on the whole, kind of boring. But it's a pleasant boring, and there's definitely something to be said for that."
Rebecca Silverman of Anime News Network gave the first episode of the anime a score of 2/5 stars, criticizing it for omitting some details from the novel, but praised the visuals for Noela. She described the series as being "just okay, and mostly it reminds me that I wish it was Kennoji's other title, Hazure Skill, that got the anime series."